Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Education Hospital All Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management GuidanceRelease Date:Partner: Japanese Dermatological AssociationQuality Improvement Inflammation & Immunology Japan Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease All Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Growth Hormone Research- United StatesRelease Date:Research Rare Disease USA Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)Release Date:Education Hospital All Topical Hemostasis in Hospital Outpatient and Ambulatory SurgeryRelease Date:Education Hospital USA Education for Improving Appropriate Diagnosis and Treatment for Venous ThromboembolismRelease Date:Education Internal Medicine Japan Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic EmbolismRelease Date:Quality Improvement Internal Medicine Japan Atopic Dermatitis and Alopecia AreataRelease Date:Quality Improvement Inflammation & Immunology Canada Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada, EMD SeronoQuality Improvement Oncology Canada Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary ImmunodeficienciesRelease Date:Education Hospital USA Knowledge Gaps in the Prevention of COVID-19 in EuropeRelease Date:Education Vaccines All Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary TeamsRelease Date:Education Rare Disease USA Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer PatientsQuality Improvement Oncology USA Educational Projects for Healthcare Professionals to Promote Cancer Patient SupportRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Latin America Needs Assessment of Prostate CancerRelease Date:Education Oncology All Menopause and Mental HealthRelease Date:Education Internal Medicine USA Efforts to Promote an Environmental Improvement for Cancer Genomic MedicineRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer TreatmentRelease Date:Education Oncology Japan Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal diseaseRelease Date:Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)Release Date:Education Internal Medicine All Rheumatology Education Healthcare DisparitiesRelease Date:Education Inflammation & Immunology USA Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic BladderRelease Date:Education Internal Medicine Japan Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia TreatmentsRelease Date:Education Rare Disease Japan Equity in Access to Cancer Cachexia Clinical TrialsRelease Date:Quality Improvement Internal Medicine All Infectious Disease FellowshipRelease Date:Fellowship Hospital India Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)Release Date:Fellowship Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Mayo ClinicReview Process: Expert Review PanelQuality Improvement Rare Disease All 2022 Growth Hormone ResearchRelease Date:Research Rare Disease All Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science ResearchRelease Date:Research Vaccines USA New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel DiseasesRelease Date:Quality Improvement Inflammation & Immunology Canada Improving the Care of Patients with Disorders of Impaired GrowthQuality Improvement Rare Disease All Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)Release Date:Education Vaccines Japan Increasing the Awareness of the Importance of Vaccination during PregnancyRelease Date:Education Vaccines Japan Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Capacity Building for Antimicrobial StewardshipRelease Date:Education Hospital Japan Implementation of Systemic Treatment Approaches in Atopic DermatitisRelease Date:Quality Improvement Inflammation & Immunology China Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)Release Date:Partner: Mayo Clinic Global Bridges OncologyQuality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe Improving Clinical Management for Patients with Breast Cancer in ChinaRelease Date:Quality Improvement Oncology China NSCLC Cancer Precision Diagnosis and TreatmentRelease Date:Quality Improvement Oncology China Advancing Management and Care in Atrial Fibrillation and Venous ThromboembolismEducation Internal Medicine All Addressing Knowledge Gaps in Aplastic AnemiaRelease Date:Education Hospital All Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient SettingsRelease Date:Education Hospital All Digital Education to Address Patients with COVID-19 and High Risk of ComplicationsRelease Date:Education Hospital All